Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Xtent Inc (XTNT)
since 2007 are illustrated in Table 1 and Table 2.
Table 1 shows the monthly insider trading data at Xtent Inc.
Table 2 shows the detailed insider transactions.
The reporting company's CIK number is 1212235.
Total stock buying since 2007: $432,000.
Total stock sales since 2007: $674,541.
Total stock option exercises since 2007: $11,000.
Table 3. Detailed insider trading at Xtent Inc (XTNT)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-10-01 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 5,000 | 1.34 | 6,680 |
| 2008-09-02 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 5,000 | 2.02 | 10,100 |
| 2008-08-01 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 2.56 | 8,967 |
| 2008-07-18 | Walsh Brian J (Other) | Option Ex | 10,000 | .40 | 4,000 |
| 2008-07-01 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 2.43 | 8,505 |
| 2008-06-02 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 3.46 | 12,127 |
| 2008-05-01 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 3.50 | 12,250 |
| 2008-04-24 | Walsh Brian J (VP-Sales & Marketing) | Sale | 3,000 | 4.12 | 12,375 |
| 2008-04-23 | Walsh Brian J (VP-Sales & Marketing) | Sale | 3,000 | 4.55 | 13,655 |
| 2008-04-02 | Grainger Jeffry J (VP-Corp Affairs & Gen. Counsel) | Sale | 3,000 | 4.94 | 14,820 |
| 2008-04-01 | Kahlenberg Timothy D (Chief Financial Officer) | Sale | 1,000 | 5.03 | 5,025 |
| 2008-04-01 | Kahlenberg Timothy D (Chief Financial Officer) | Option Ex | 1,000 | 3.50 | 3,500 |
| 2008-04-01 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 5.00 | 17,500 |
| 2008-04-01 | Grainger Jeffry J (VP-Corp Affairs & Gen. Counsel) | Sale | 2,000 | 5.03 | 10,050 |
| 2008-04-01 | Casciaro Gregory D (President and CEO) | Sale | 2,000 | 5.03 | 10,050 |
| 2008-03-03 | Kahlenberg Timothy D (Chief Financial Officer) | Sale | 1,000 | 7.11 | 7,113 |
| 2008-03-03 | Kahlenberg Timothy D (Chief Financial Officer) | Option Ex | 1,000 | 3.50 | 3,500 |
| 2008-03-03 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 7.05 | 24,682 |
| 2008-03-03 | Grainger Jeffry J (VP-Corp Affairs & Gen. Counsel) | Sale | 5,000 | 7.07 | 35,335 |
| 2008-03-03 | Casciaro Gregory D (President and CEO) | Sale | 2,000 | 7.07 | 14,134 |
| 2008-02-04 | Casciaro Gregory D (President and CEO) | Sale | 2,000 | 9.78 | 19,550 |
| 2008-02-01 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 9.65 | 33,778 |
| 2008-02-01 | Grainger Jeffry J (VP-Corp Affairs & Gen. Counsel) | Sale | 5,000 | 9.55 | 47,750 |
| 2008-01-25 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 7,000 | 10.02 | 70,154 |
| 2008-01-03 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 1,400 | 9.11 | 12,748 |
| 2008-01-02 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 2,100 | 9.72 | 20,422 |
| 2007-12-26 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 1,700 | 10.00 | 17,000 |
| 2007-12-06 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 9.14 | 31,983 |
| 2007-11-01 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 7,000 | 10.01 | 70,056 |
| 2007-10-18 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 10.01 | 35,035 |
| 2007-10-01 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 8.51 | 29,767 |
| 2007-09-04 | Marco Philippe H (VP-QA, Clinical & Reg. Affairs) | Sale | 3,500 | 7.96 | 27,853 |
| 2007-02-06 | Bellas Robert C Jr (Director) | Buy | 25,000 | 16.00 | 400,000 |
| 2007-02-06 | Flaherty Robert E (Director) | Buy | 2,000 | 16.00 | 32,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
of XTNT listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Xtent Inc (symbol XTNT,
CIK number 1212235) see
the Securities and Exchange Commission (SEC) website.